SCOPE Stem Cell Roundup: May 19
This Week – Translation, Unproven, Marketing, Dropped Ban, Diabetes, Haploid, + Much More
courtesy of the Stem Cell Policy and Ethics (SCOPE) program: a collaborative effort of the Johns Hopkins Berman Institute of Bioethics and the Johns Hopkins Institute for Cell Engineering.